STERIS plc — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2023-05-31

Reporting Person: Majors Cary L (SVP and President, Healthcare)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-31	Ordinary Shares	F	649	$199.97	Disposed	10696	Direct
2023-05-31	Ordinary Shares	A	2697	$0.00	Acquired	13393	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-31	Employee Stock Option (right to buy)	$219.97	A	15148	Acquired	2033-05-31	Ordinary Shares (15148)	Direct

Footnotes

F1: 649 shares were withheld from the 2,224 restricted shares that vested on May 31, 2023. These 649 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,224 ordinary shares were awarded to Mr. Majors on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023.

F2: As of May 31, 2023, 9,860 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026 and 2,140 on June 2, 2026.

F3: This option becomes exercisable as follows: 3,787 on May 31, 2024; 3,787 on June 2, 2025; 3,787 on June 1, 2026 and 3,787 on June 1, 2027.